GLO Pharma
Encinitas, US · Founded 2018 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JM
Jana MessersmithDirector
LO
Lauren OtsukiDirector
SG
Scott GlennExecutive Officer, Director
TJ
Todd JacksonDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$53MraisedSep 2023 · 189 investors · BiotechnologyRule 506(b)
▶$53MraisedSep 2023 · 189 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dayna QuanbeckDirector
- Nicole QuinnDirector
- Marla BeckDirector
- Maureen CaseDirector
- Fabian SeelbachDirector
- Douglas WallDirector
- Lauren OtsukiDirector, Executive Officer
- Vimla Black-GuptaExecutive Officer, Director
- Offering amount
- $53M
- Amount sold
- $53M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.8MraisedNov 2020 · 20 investors · PharmaceuticalsRule 506(b)
▶$6.8MraisedNov 2020 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jana MessersmithDirector
- Lauren OtsukiDirector
- Scott GlennExecutive Officer, Director
- Todd JacksonDirector
- Offering amount
- $6.8M
- Amount sold
- $6.8M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$511KraisedNov 2020 · 22 investors · PharmaceuticalsRule 506(b)
▶$511KraisedNov 2020 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott GlennExecutive Officer, Director
- Jana MessersmithDirector
- Todd JacksonDirector
- Lauren OtsukiDirector
- Offering amount
- $511K
- Amount sold
- $511K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.